• RFID MEMs origami that changes its physical shape slightly to make RFID

    From Treon Verdery@21:1/5 to All on Sat Oct 8 05:09:11 2022
    It might be a big dataspace: 700 integer space factorial RFID that changes its RF responsiveness from MEMs at 700 factorial different data values it is possible that at 300 Hz (like LCD driver, and although there are a variety of RFID forms, changing
    the shape of an metal rish liquid crystal LCD blob could actually be an RFID object) this could communicate updates 300 times a second as well as have the RFID store some amount of previous snapshots of actual EEG output at the person, noting the
    factorial space, it is possible 700 factorial could represent multiple centuries of EEG data recorded at 300Hz



    Some thing at phones where something has, more than a bluetooth ID, an instant shared automatic data update database compartment, where anytime the thing is brought near the phone, its compartment identity data is appended with the new data. So rather
    than “synch” a smartwatch with a phone or computer, the mere presence of the smartwatch, health monitor, EEG recorder, data depot, like say a person has a data depot where not only is the video and audio and other data from the cameras on their body
    continually aggregated and concatenated, but the social norm automatic protocol is to have all the video, audio, and other data cameras around the person wherever they go upload their data to the person, that is human’s that is member of a group of
    people’s that is homo sapiens’ data depot, that data depot is automatically uploaded to the persons’ phone, computer, and the phones computers and data depots of those that have configured their data depots, phones and computers to I’m nice
    configuration (a little like when other people make their wifi public, give to food banks, donate to strangers that ask for donations, or say things like “good to see you”; lots of people would automatically gather and store and make public data) I
    think the storage per microgram will go up, at 2019 AD a terabyte of data is plausibly anywhere from less than 10 micrograms (data storage variant on DNA with a few thousand different nucleutides as rung options) to 100 mg (microSD card)





    Nonsexy, but, genital sourced nootplanes that are beneficial



    Banishing lonliness with a 1000 year functional depot injection or possibly as a combined effect with another drug could cause 26% less mortality, ““Imagine a condition that makes a person irritable, depressed and self-centred, and is associated with
    a 26 per cent increase in the risk of premature mortality,” Cacioppo and her late husband, John Cacioppo, wrote in The Lancet last year. Around a third of people in industrialized countries report feeling lonely, one in 12 severely so” https://
    nationalpost.com/health/all-the-lonely-people Notably the steriodal hormone pregnenolone has been researched as an anti-loneliness drug, and as a sex steroid like molecule could have ethynylization as well as halogenation as effective dose multipliers;
    the first page of a search engine suggests 10 times greater effect per dose, if ethynylization is 8 times greater dose efficacy then 80 times fewer micrograms per dose could be possible; at .625 mg as a daily estrogen dose, and 300-800 nanogram/24 hours
    at ethynylized estrogens or possibly progesterones (progestins), the fluorinated version could be active at 30-80 nanograms/24 hours, or a .333 gram depot injection providing 365,000 to one million gradually diffused 1microgram to 100 nanogram doses at a
    one office visit dose treatment for loneliness, a 1000 to 10,000 year duration of loneliness reduction if pregnenolone has a ethynyl and fluoro dose amplified form. If a lymphatic system applied depot form of ethynylated halogenated progesterone is
    possible that approximately quadruples physiological availability from omitting first pass metabolism; if a blood brain barrier passing moeity is a possible modification as well a two to ten times greater availability at the CNS, a possible location of
    feelings of loneliness could be possible, so 80 nanograms /4 /2 is 10 nanograms per 24 hour dose, permitting an approximately 40 milligram 1000 year duration depot injection dose. Notably, if it is possible to make an oral depot version of a drug,
    possibly from antibodies linked to palmitates, with the antibodies specific to lymphatic epithelia, then at 10% efficiency compared with an injected depot a 400 mg depot producing oral dose with 1000 year depot functionality of a ethynyl
    fluoropregnenlolone could be possible; gene therapy or also germline gene therapy to produce more pregnenolone, or shift to personality genetics that is absent feelings of lonliness; also noting that the big five personality test trait areas are about 50%
    heritable, and that a new personality test where, like the minnesota multiphasic personality inventory the questions were correlated, winnowed, and enhanced to be predictive, it is possible a 97-99% genetically predictable paper question or also
    software psychology test with completely fresh new traits that could also be called themes could be constructed. If some percentage of these traits or themes that are 97-99% genetically predictable are the kinds of things people would change to improve
    their well being, efficacy, ability, and prosociality, reduce or prevent loneliness, while maintaining or expanding creativity and initiative then those are rapidly eugenics addressable traits and themes that could also be gene therapy opportunities.



    Addressing loneliness with depot drugs or causing greater plasma levels from less pregnenolone metabolism, whichever is more physiologically beneficial could reduce mortality 26%. It is unknown if numerous species of mammals along with humans experience
    loneliness, gene drive could banish loneliness at perhaps all mammals; the effect on frequency of mating and the number of progeny is unknown, but imaginably increases among all mammals that experience an absence of loneliness.



    Moieties that cause higher physiological availability and physiological activity at a particular mg (or mcg or ng) dose; I read that halogenated drugs are less metabolized at the liver with things like CYP enzymes, that gives longer plasma duration, as
    well as possibly omits first pass metabolism, causing, imaginably, 90% or higher amounts of the drug to remain fucntional at the circulatory system; It could be that there is a kind of drug visiting and detaching from receptors many times, as well as
    what I previously thought that halogenated drugs glom on to receptors and have long residence intervals from their high electronegativity glomming and staying on a receptor; also it is possible that halogenated drugs, as well as other drugs, which get
    some of their durability from plasma from glomming to albumins, globulins, or other plasma proteins could have versions that glom to plasma proteins twice as avidly, or perhaps are absent any plasma protein glomming; a fluorodrug without plams protein
    glomming might go almost completely unmetabolized at the liver, yet have a tissue available dose 7-9 times higher from an oral or other dosing; alternately, double duration plasma protein glomming



    screen a library: radiolabelled or fluorophore labelled halogenated drugs, a few thousand, million, billion, or at a 300mm integrated circuit wafer with 1 trillion wells



    Rapamycin, with like a trifluoro (methyl group like with three fluorines) that has 16 day or longer plasma half life, different plasma protein glomming could be an even more effective enhanced human longevity drug, from persisting at the circulatory
    system longer; noting the mice that lived 60% longer from 126 ppm rapamycin had frequent meals but, I perceive I may have read, 9 minute rapamycin plasma half life, and I might have read human plasma half life of rapamycin might be .9 hours while
    wikipedia says 57-63 hours; higher plasma protein glomming of a rapamycin; wikipedia says rapamycin is 92% protein glommed, there is some possible greater sustained rapamycin longevity effect there that could be produced and be beneficial; wikipedia
    says, “ Since albumin is alkalotic, acidic and neutral drugs will primarily bind to albumin.”; Although a trained professional would know much more, the longest plasma half life of a drug I am aware of is norfluoxetine, 16 days, 384 hours; perhaps
    the chemistry of such drugs (trifluoride like a methyl) could be used to produce even more beneficial, possibly even more longevizing variations of rapamycin, noting the mice were likely eating food perhaps every few minutes at the 126 ppm enteric coated
    rapamycin dose; At the rapamycin molecule I read that a /\/\/\/\ with numerous \=/=\=/=\=/ is thought to be the mTOR active part of rapamycin, and it has a methyl on it that if replaced with a trifluoro methyl like moeity could cause the ten times
    greater plasma half life. It is different than other things I have read, but wikipedia says ascorbic acid has a circulatory system half life of 83 days, with an eleimination constant of 4 months, that suggests something as simple as screening a variety
    of locations of an ascorbic acid moeity could make a 3 month dose of a longevity producing rapamycin varaint; also I perceive I read that rapamycin’s oral absorption has to do with rapamycin’s nonsensitivity to pH, a rapamycin ascorbic acid version
    could have higher effective drug absorption at a particular mg or ppm at food dose;



    Longevity drug: 126 ppm rapamycin is published as making mice live 60% longer, it is my perception that I read this has to do with reducing mTOR activity, notably though mice with mTOR -/- genes, which I pereceive as meaning they have zero mTOR receptors
    live 20% longer; It seems possible that at mammals with mTOR receptors the mammals might also be making previously unstudied slightly hormesis-like chemicals that cause other changes at the body to compensate or emeliorate for having mTOR receptors, and
    possibly reducing the activity of things (networks) connected to mTOR receptor activation; those slightly hormetic like ameliorators persist at the mammals when rapamycin causes the 60% greater mouse lifespan yet at the -/- mtor mice are minimally there (
    genes that produce the ameliorating chemicals) as they do not need to be. Finding those physiochemicals, likely proteins, receptor proteins or material at the cytoplasm then adminstering them to mammals as separate longevity chemicals as drugs could
    have the 40% longevity increase that could be linked to 60% increased longevity mice (minus) 20% at mice with no mTOR receptors; At humans, production of these chemicals, proteins, or peptides could be endogenous with germline gene modification or also
    gene therapy; The possibly attainable 40% greater longevity from other mTOR receptor presence ameliators might even have different tissue or cyte localizations, potentially concentrating longevising effects, or finding areas to bring up to the body
    tissue longevity increasing median, which would cause greater youthfulness of phenotype as well as greater longevity; looking at all the mRNA that rapamycin causes the production of, and comparing it to the mRNA that the mTOR -/- mice when adminstered
    rapamycin make could find the ameliator 40% greater longevity genes and chemicals, just administering rapamycin to the mTOR -/- mice could find the 40% longevity mTOR ameliorating chemicals, genes, and proteins or peptides from mass characterizations at
    all the proteins and peptides produced at the mammals.



    Moving a math distribution of longevizing drug effects with bulk-effect different longevity drugs, and comparing that to a conctenated tissue and cyte approach; is there published research on the distribution of phenotypic and genotypic youthification of
    form (variously somatic form or things like telomeres or mRNA expression profiles) at different cytes and tissues, It is possible an equation, computer model, or predictive AI would be much better, although one way to think of this is like a histogram;
    if the histogram has a normal distribution then 32% of tissues and cytes are high longevity responders, 68% are at the first standard deviation; broad-group differences in distribution shape, and addressing which cytes and tissues are at what standard
    deviation could be a programmatic way to find composite longevity drug combinations that cause a chemical that causes the phenotypic or also genotypic central standard deviation of one drug to be at the 2nd standard deviation of longevization with
    another drug; this bulk mathematical effect complements the other idea of finding things like: one thing functions at adipose tissue, one thing works at neurons, another thing works at the cardiovascular system, another works on preventing cancer then
    assembling a multitissue multicyte addressing multidrug blend; both have value, it is just that addressing entire distributions to move up an entire standard deviation of longevity increase could be accomplished with particularly larger affordability,
    and simplicity.



    Numerous math approaches, or groups of drugs/activities/genetic enhancements could be numerically modelled or equation limned to find the component groups that most functionally cause longevizing distribution standard deviation shifts, overlays, and
    complementary groups; Receptor based, like AMPK and less mTOR, ILGF-1, and possibly receptors activated from published as causing 25-27% greater mouse longevity royal jelly chemicals or proteins, could be a standard deviation described group; then a
    completely different chemical group of nonreceptor longevity increasing drugs could be another distribution group, like senolytics; a third group could be what I read about that might be called “mortality reducers” epithalon combined with thymosin
    causes four times fewer people to have mortality events after six years, preventing, curing, or also genetically precluding loneliness reduces mortality 26%, I perceive there are other mortality reducers; another producible group that could actually
    cause standard deviation overlap and movement of more things to second deviation or higher of greater longevity effects is to just make lipophilic and hydrophilic variations on the most effective longevity drugs; a hydrophilic and lipophilic version of
    the rapamycin molecule and other receptor molecules, a lipophilic and hydrophilic version of senolytics, a lipophilic and hydrophilic version of 17 alpha estradiol, a lipophilic and hydrophilic version of the 25-27% greater longevity royal jelly proteins
    or other chemicals; Also possibly lipophilic and hydrophilic and lymphatic system versions of what might be non-receptor longevity drugs like spermidine, immunizations, and NMN, could each modify the distributional histogram of effectiveness, which might
    be a normal distribution at any one group of longevity drugs that could combine to move as many tissues and cytes as possible to produce an almost three-phase power like graph with all three phases being at the second deviation (upper 32%) of higher of
    longevity effect.



    A three of four drug blend that shifts entire distributions could have, perhaps based on the math of drug combination alone, many fewer numerically predictable side effects or contraindications than a 400 tissue or 400 cell type multihundred drug
    composite. Then again, if each of the 400 drugs or gene products individually causes greater longevity and wellness, then their harmlessness might be kind of definitionally adequate, sort of, if it makes you live longer, and makes you weller, its
    harmlessness is definitionally adequate. Note though that testing and time to commercialization could be much quicker with 10 highest effect longevity drugs times 6 variations (lipophilic, hydrophilic, halogenated and ethynylized, depot form, lymphatic
    area, gene based, ) than testing and time to commercialization of a multihundred drug form. Notably though there are numerous opportunities for tremendous benefit from individual drugs as well, gene therapy or also germline modification to produce
    longevity and mortality reducing peptides (epithalon with thymosin 4 times mortality reduction)



    Mass screening of longevity drug candidates with vertebrates: Fish: some fish (a goby) have median lifespans of 60 days, others like guppies, 2 years; A fish listed online is .55 inch (1.4 cm), Danionella, “When the genus was first described, these
    fish were classified as the smallest adult vertebrates to inhabit freshwater”; Other fish in the .75 inch to 1 inch size are described at https://www.myaquariumclub.com/nano-fish-for-small-aquariums-5134.html; Some fish may have greater cognitive
    ability than some other fish, “Dwarf puffers are one of the few species of fish that interact with their environment and owner. They will happily greet you as you approach the tank, and can even learn to be hand fed.”; another consideration for mass
    screening of longevity molecules and longevity genetics and wellness molecules and wellness genetics at vertebrates is absence of aggression; it is possible that at a communal growth tank frequent fish-fish interaction of a nonpleasant nature could
    affect physiology, actual physical integrity, and even the effects of stress on longevity;



    Mass screening the fish: at 1 second per fish, a 3d printed 100 fish hydrosorter processes 1 million vertebrate fish for longevity drug efficacy at 10,000 seconds or 167 minutes (2.8 hours); A different engineering version: noting tube lengths, even with
    green light causing many fish to prefer forward travel, at 10 seconds per fish, and a 1000 fish (32 times 32 grid) hydrosorter process it is also 2.8 hours to characterize and label 1 million fish; 117 days screens 1 billion fish.



    The hydrosorter could be 3d printed so a fresh, absent algae coating, predictable fluid flow hydrosorter is available anytime. One Kg of 3d printing filament is $29; If the hydrosorter has a mass of 1 Kg or likely much less, then a 3d printed version is $
    29 That makes CAD development of greater and greater efficacy hydrosorters more rapid, and causes the most complex part to be $29, disposable, and like PLA (polylactic acid), physiologically compatible and harmless.



    At the growth tank, fish can be taught light stimulated fish behaviors, green could mean swim towards something, possibly a food source that will dispense food in 2-7 seconds; Blue light could teach the fish to be stationary in the water, possibly
    facilitating imaging, Aqua light could be linked to the learning of a 3-7 sequence action the fish could perform for the cameras at the hydrosorter, providing data on cognitive effects at progressive living, White light could teach fish to expect change
    without stress; perhaps a mini version of the hydrosorter at the growth tank, only without the cameras, lasers, and other imagers;



    Cognitive or cognitive like-distribution shifts, could be measured at the hydrosorter, with accuracy of the aqua light learned sequence, and with efficacious cameras and software, inter-motion time, kind of like velocity of recall; To keep fish moving
    through the 1000 channel hydrosorter there could be green light stimulated fish preference for forward travel,



    To label individual fish for further study, GFP or another photoshiftable color, then a laser, absent effect on actual fish tissue, barcodes the fish with photochemical modification of just the GFP at 1 million fish labelled each 2.8 hours, also, all the
    fish that go through the hydrosorter, notably the labelled fish, can be reused from the after hydrosorter tank, to multiplex treatments; Also, fish the software notes to be of particular interest, like the youngest phenotype fish out of each million, or
    if the fish seem euphoric, unusually physically active, or displays mating behaviors at the camera area of the hydrosorter then those effects, potentially beneficial at mammals, can be linked to the longevity chemicals and genes being screened;



    There are numerous ways to administer longevity drugs to fish, the hydrosorter could dispense a couple drugged food pellets at a particular area of the hydrosorter, where the mechanism at the hydrosorter could utilize something like n=40 for each
    different longevity drug, to administer 25,000 different longevity drugs in 2.8 hours, if the fish get 3 hydrosorter administered doses, separated at 24 hours each, then a full hydrosorter imaging, that is 11.2 hours spread over 96 hours at an automatic
    system; I once had a motorized automatic fishfeeder that was about $29.99; Another possible way to administer drugs to fish is to have something like an inkjet printer spray them with a gelcoat, another way is to have the hydrosorter have the fish
    breathe drugged water through their gills for a minute at one area of the hydrosorter;



    Fish vertebrate research supporting well and longevized human babies: one benefit of using vertebrates like fish as longevity drug development and effectiveness verifiers is that some fish are livebearers of young, this provides an opportunity to see if
    there are any beneficial new drug distribution shifting effects of well progeny; it is possible some longevity drugs as well as genes actually heighten fetal and baby wellness, scanning a million fish in 2.8 hours is one way to find drugs that can then
    be tested on mammals like mice to find out if fetal and baby well being are increased at mammals as well.





    The hydrosorter could be a little like the top view of the internal crenellations of cardboard at about 14 mm width, with sensors tht can see through the 3d printed polymer or a transparent plastic plate on top of the hydrosorter, so one or more cameras
    can image the 1000 simultaneous fish for software processing; Notably things like THz imaging of the fish could work through the 3d printed polymer and the software could record things like organ size and skeletal density, and gill respiration rate, and
    heartrate, Also, light cameras placed at CAD optimized ports at the 3d printed hydrosorter are also possible, and general soft illumination provided through the 3D printed volume with external lighting;



    With positron emission tomography and radiolabelled physiochemicals like like radiolabelled longevity drugs that effect neurons, radiolabelled neurotransmitters, other tissues and molecules, as well as concentration and multiple measurements with time
    activity at the physiological tissues with the least vascularization, Then variations or shifts from the longevity drug molecule compared with untreated fish’ distribution of tissue activities and neural function can be gathered as data at a computer
    and mapped; it is also possible that noting the 25,000 groups of n=40 fish (1 million) screened each 2.8 hours, that a variety of longevity drug localization effects will be found, and finding out which chemical concentrates where has longevizing and
    wellness value.



    One use of the unique fish ID produced at something like a laser on GFP is the production of a library of frozen fish, possibly with detectable mRNA activity or things having other technology and drug development value, live clonability from the frozen
    fish, also detailed study of the 20-100 most efficacious longevity drugs’ per million fish characterized effect on things like cytoplasm, reproductive anatomy (sperm, eggs, livebearer growth areas), brain morphology, telomere length, cardiovascular
    fitness, cancer amount, and immune system effects;



    One area of longevity molecule research doable at fish at a hydrosorter, is the longevizing effects of reducing the amounts of some molecules from tissues or at circulation; It is possible the hydrosorter could be used to administer gill-breathable
    antigens (immunizations) against things like interleukins, sex hormones that are absent effects on secondary sex characteristics yet have cardiovascular risks or carcinogenic effects, liver enzyme saturating endogenous chemicals, mTOR activators, ILGF-1 (
    and similar molecules), endogenous telomere length reducing molecules, endogenous AMPK activity decreasing chemicals, possibly some versions of cortisol-like molecules circulating endogenously, physiochemicals that get upregulated when organisms miss
    sleep and could be deleterious (missing one night of sleep doubles likelihood of infection at a human); peptides (or proteins)that cause stress, possibly like deleterious versions of beneficial peptides (or proteins) that occupy beneficial receptors, but
    have zero or negative activity, keeping the beneficial forms of those peptides (or proteins) from reaching the receptors and providing benefit, various lipopolysaccharides that might reach the circulatory system from the GI tract, histamine, the
    physiological chemicals produced at gum disease that I read is like 20something to 48% active at causing cardiovascular disease, Any endogenous physiochemicals that cause heart rythms outside the wellness standard (although these are of course fish), as
    well as, noting that a combination of epithalon with thymosin causes four times less mortality during six years at humans, any chemicals that occupy epithalon and thymosin receptors causing those receptors to not function at preserving living function.



    A peltier enabled hydrosorter used at fish could also be used to develop cryogenic cryoprotectants to support human cryonic preservation and revival.

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)